Chinese expert consensus on endocrine therapy for breast cancer (2026 edition)

Key Points

• Individualized treatment for HR-positive breast cancer is emphasized, enabling better patient outcomes.
• The clinical guidance aims to standardize the application of endocrine therapy, improving treatment efficacy.
• The consensus reflects current expert opinions and practices in the management of breast cancer.
• Adopting this guidance may lead to more precise therapeutic approaches and improved patient care.

Abstract